Despite a comparatively small population by European standards, Ireland’s macroeconomic indicators remain healthy, with strong GDP growth rates.
Ireland is globally competitive in terms of flexibility, adaptability, human resources, culture, and economic policy.
Ireland’s tax regime is also globally competitive, with favourable corporate tax rates, R&D tax credit, and an excellent IP tax regime.
Compared to other pharma powerhouses across Europe and the world, Ireland’s corporate tax rates are comparatively low and extremely favourable to investors.
After taking a hit following the financial crisis and subsequent slump, Ireland’s economy is well on the road to recovery with year on year PPP GDP growth since 2012.
Along with GDP growth, Ireland’s unemployment rate has steadily been decreasing since 2012.
Top 10 Pharmaceutical Employers in Europe: Ireland punching above its weight.
Top 10 Pharmaceutical Producers in Europe: Ireland number five, ahead of the UK!
In 2015, Ireland exported more pharmaceuticals than ever before (EUR 30.2 billion), while also importing more (EUR 5.7 billion).
Ireland’s biopharma industry is a major employer, revenue generator and exporter, and is set to grow more with further investments slated for the coming years.
Mapping Irish Biopharma: Dublin and Cork are the two most important biopharma clusters in Ireland.
Key indicators for healthcare in Ireland.
Ireland has the highest percentage of its population under 25 years old in Europe (33.3 percent).
Ireland’s epidemiological profile with the major causes of death and prevalent health conditions.